D-cycloserine in the Management of Chronic Low Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

November 30, 2014

Conditions
Low Back PainPain
Interventions
DRUG

D-cycloserine

D-cycloserine 50 mg bid; D-cycloserine 100 mg bid; D-cycloserine 200 mg bid

DRUG

placebo

placebo bid

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Thomas J. Schnitzer

OTHER

NCT00125528 - D-cycloserine in the Management of Chronic Low Back Pain | Biotech Hunter | Biotech Hunter